|
[1]
|
Hampel, H., Prvulovic, D., Teipel, S., Jessen, F., Luck-haus, C., Frolich, L., Riepe, M.W., Dodel, R., Leyhe, T., Bertram, L., Hoffmann, W. and Faltraco, F. (2011) The future of Alzheimer’s disease: The next 10 years. Progress in Neurobiology, 95, 718-728.
doi:10.1016/j.pneurobio.2011.11.008
|
|
[2]
|
Contino, M., Cantore, M., Leopoldo, M. and Colabufo, N.A. (2013) Biomarkers for the early diagnosis of Alzheimer’s disease: The challenge of XXI century. Advances in Alzheimer’s Disease, 1, 13-30.
doi:10.4236/aad.2013.21003
|
|
[3]
|
Braak, H. and Del Tredici, K. (2012) Where, when, and in what form does sporadic Alzheimer’s disease begin? Current Opinion in Neurology, 25, 708-714.
doi:10.1097/WCO.0b013e32835a3432
|
|
[4]
|
Cai, Y., Xiong, K., Zhang, X.M., Cai, H., Luo, X.G., Feng, J.C., Clough, R.W., Struble, R.G., Patrylo, P.R., Chu, Y., Kordower, J.H. and Yan, X.X. (2010) β-Secretase-1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. European Journal of Neuroscience, 32, 1223-1238.
doi:10.1111/j.1460-9568.2010.07376.x
|
|
[5]
|
Radak, Z., Hart, N., Sarga, L., Koltai, E., Atalay, M., Ohno, H. and Boldogh, I. (2010) Exercise plays a preventive role against Alzheimer’s disease. Journal of Alzheimers Disease, 20, 777-783.
|
|
[6]
|
Stern, Y. (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neu-rology, 11, 1006-1012.
doi:10.1016/S1474-4422(12)70191-6
|
|
[7]
|
Skaper, S.D. (2012) Alzheimer’s disease and amyloid: Culprit or coincidence? International Review of Neurobiology, 102, 277-316.
doi:10.1016/B978-0-12-386986-9.00011-9
|
|
[8]
|
Swerdlow, R.H. (2012) Alzheimer’s disease pathologic cascades: Who comes first, what drives what. Neurotoxicity Research, 22, 182-194.
doi:10.1007/s12640-011-9272-9
|
|
[9]
|
Marques, S.C., Oliveira. C.R., Outeiro. T.F. and Pereira. C.M. (2010) Alzheimer’s disease: The quest to understand complexity. Journal of Alzheimers Disease, 21, 373-383.
|
|
[10]
|
Mullane, K. and Williams, M. (2013) Alzheimer’s therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—But what lies beyond? Biochemical Pharmacology, 85, 289-305.
doi:10.1016/j.bcp.2012.11.014
|